Format
Sort by

Send to

Choose Destination

Search results

Items: 3

1.

Community-associated methicillin-resistant Staphylococcus aureus and healthcare risk factors.

Klevens RM, Morrison MA, Fridkin SK, Reingold A, Petit S, Gershman K, Ray S, Harrison LH, Lynfield R, Dumyati G, Townes JM, Craig AS, Fosheim G, McDougal LK, Tenover FC; Active Bacterial Core Surveillance of the Emerging Infections Program Network.

Emerg Infect Dis. 2006 Dec;12(12):1991-3.

2.

Effect of introduction of the pneumococcal conjugate vaccine on drug-resistant Streptococcus pneumoniae.

Kyaw MH, Lynfield R, Schaffner W, Craig AS, Hadler J, Reingold A, Thomas AR, Harrison LH, Bennett NM, Farley MM, Facklam RR, Jorgensen JH, Besser J, Zell ER, Schuchat A, Whitney CG; Active Bacterial Core Surveillance of the Emerging Infections Program Network.

N Engl J Med. 2006 Apr 6;354(14):1455-63. Erratum in: N Engl J Med. 2006 Aug 10;355(6):638.

3.

Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine.

Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH, Schuchat A; Active Bacterial Core Surveillance of the Emerging Infections Program Network.

N Engl J Med. 2003 May 1;348(18):1737-46.

Supplemental Content

Loading ...
Support Center